C07C 311/05
To acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not
Official title: to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
C07C311/05 (To acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not) appears on 157 US grants and 138 published applications in this corpus.
Search patents in C07C- Granted patents
- 157
- Published applications
- 138
- Assignees
- 91
- Inventors
- 498
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 8 | 0 |
| 1999 | 2 | 0 |
| 2000 | 3 | 0 |
| 2001 | 7 | 1 |
| 2002 | 10 | 5 |
| 2003 | 12 | 9 |
| 2004 | 6 | 13 |
| 2005 | 4 | 9 |
| 2006 | 7 | 7 |
| 2007 | 5 | 7 |
| 2008 | 4 | 3 |
| 2009 | 3 | 5 |
| 2010 | 5 | 8 |
| 2011 | 0 | 3 |
| 2012 | 3 | 7 |
| 2013 | 4 | 4 |
| 2014 | 5 | 8 |
| 2015 | 9 | 1 |
| 2016 | 5 | 5 |
| 2017 | 3 | 7 |
| 2018 | 5 | 6 |
| 2019 | 9 | 4 |
| 2020 | 2 | 4 |
| 2021 | 6 | 4 |
| 2022 | 3 | 6 |
| 2023 | 0 | 4 |
| 2024 | 3 | 3 |
| 2025 | 3 | 2 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents2 Sep 2025US 12,404,232 B2ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents10 Jun 2025US 12,324,859 B2ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents1 Apr 2025US 12,263,248 B2ModernaTX, Inc.
- Decarboxylase inhibitors for treating Parkinson's disease10 Dec 2024US 12,162,902 B2Sail Biomedicines
- Ionizable amine lipids6 Aug 2026US 2026/0225997 A1Intellia Therapeutics, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents19 Mar 2026US 2026/0078082 A1ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents12 Mar 2026US 2026/0069549 A1ModernaTX, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents17 Jul 2025US 2025/0228777 A1ModernaTX, Inc.
- Aryl alkynamide derivatives5 Jun 2025US 2025/0177349 A1Astellas Engineered Small Molecules US, Incorporated
Most cited
By later US patents
- Compounds and compositions for intracellular delivery of therapeutic agents143US 9,868,691 B2ModernaTX, Inc. · 2018
- Compounds and compositions for intracellular delivery of therapeutic agents88US 10,857,105 B2MordernaTX, Inc. · 2020
- Neuropeptide Y5 receptor antagonists65US 6,329,395 B1Schering Corporation · 2001
- Compounds and compositions for intracellular delivery of therapeutic agents62US 9,868,692 B2ModernaTX, Inc. · 2018
- α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors56US 6,248,775 B1G. D. Searle & Co. · 2001